• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老挝人民民主共和国扩大疟疾诊断和治疗:公私混合举措的经验教训。

Expanding malaria diagnosis and treatment in Lao PDR: lessons learned from a public-private mix initiative.

机构信息

Center for Malariology, Parasitology, and Entomology, Ministry of Health, Vientiane, Lao PDR.

World Health Organization, Bangkok, Thailand.

出版信息

Malar J. 2017 Nov 13;16(1):460. doi: 10.1186/s12936-017-2104-5.

DOI:10.1186/s12936-017-2104-5
PMID:29132370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5683316/
Abstract

BACKGROUND

As in other countries of the Greater Mekong Sub-region (GMS), the private health sector constitutes a significant avenue where malaria services are provided and presents a unique opportunity for public-private collaboration. In September 2008, a public-private mix (PPM) strategy was launched initially in four northern and southern provinces in Lao PDR to increase access to rapid diagnostic tests (RDTs) and artemisinin-based combination therapy (ACT), improve quality of care, and collect routine malaria data from the private sector. Throughout the process, key stakeholders were involved in the planning, monitoring and supervision of project sites. Following an initial assessment in 2009, the PPM initiative expanded to an additional 14 district sites to a total of 245 private pharmacies and 16 clinics covering 8 provinces and 22 districts. By June 2016, a total of 317 pharmacies, 30 clinics in 32 districts of the 8 provinces were participating in the PPM network and reported monthly malaria case data.

METHODS

This descriptive study documented the process of initiating and maintaining the PPM network in Lao PDR. Epidemiological data reported through the routine surveillance system from January 2009 to June 2016 were analyzed to illustrate the contribution of case reporting from the private sector.

RESULTS

A total of 2,301,676 malaria tests were performed in the PPM districts, which included all the PPM pharmacies and clinics (176,224, 7.7%), proportion of patients tested from 14,102 (4.6%) in 2009 to 29,554 (10.4%) in 2015. Over the same period of 90 months, a total of 246,091 positive cases (10.7%) were detected in PPM pharmacies and clinics (33,565; 13.6%), in the same districts as the PPM sites. The results suggest that the PPM sites contributed to a significant increasing proportion of patients positive for malaria from 1687 (7.4%) in 2009 to 5697 (15.8%) in 2015.

CONCLUSIONS

Ensuring adequate and timely supplies of RDTs and ACT to PPM sites is critical. Frequent refresher training is necessary to maintain data quality, motivation and feedback. In the context of malaria elimination, the PPM initiative should be expanded further to ensure that all febrile cases seen through the private sector in malaria transmission areas are tested for malaria and treated appropriately. Results from the PPM must be integrated into a centralized registry of malaria cases that should prompt required case and foci investigations and responses to be conducted as part of elimination efforts.

摘要

背景

与大湄公河次区域(GMS)其他国家一样,私营医疗部门提供了疟疾服务的重要途径,为公私合作提供了独特的机会。2008 年 9 月,老挝人民民主共和国在北部和南部的四个省最初启动了公私混合(PPM)战略,以增加对快速诊断检测(RDT)和青蒿素为基础的联合疗法(ACT)的获取、改善护理质量,并从私营部门收集常规疟疾数据。整个过程中,利益攸关方都参与了项目地点的规划、监测和监督。2009 年进行初步评估后,该倡议扩展到另外 14 个区,共有 245 家私营药店和 16 家诊所,覆盖 8 个省的 22 个区。截至 2016 年 6 月,8 个省的 32 个区的 317 家药店和 30 家诊所参与了 PPM 网络,并每月报告疟疾病例数据。

方法

本描述性研究记录了老挝人民民主共和国启动和维持 PPM 网络的过程。对 2009 年 1 月至 2016 年 6 月通过常规监测系统报告的流行病学数据进行了分析,以说明私营部门病例报告的贡献。

结果

在 PPM 区进行了 2301676 次疟疾检测,包括所有 PPM 药店和诊所(176224,7.7%),患者检测比例从 2009 年的 14102 人(4.6%)增加到 2015 年的 29554 人(10.4%)。同期 90 个月内,PPM 药店和诊所共发现 246091 例阳性病例(10.7%)(33565 例,13.6%),与 PPM 点所在的区相同。结果表明,PPM 点有助于显著增加疟疾阳性患者的比例,从 2009 年的 1687 例(7.4%)增加到 2015 年的 5697 例(15.8%)。

结论

确保向 PPM 点提供充足和及时的 RDT 和 ACT 供应至关重要。需要经常进行复习培训,以保持数据质量、积极性和反馈。在消除疟疾的背景下,应进一步扩大 PPM 倡议,以确保在疟疾传播地区通过私营部门看到的所有发热病例都接受疟疾检测并得到适当治疗。PPM 的结果必须纳入疟疾病例的中央登记册,这应促使开展所需的病例和焦点调查,并作为消除努力的一部分作出反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/5683316/70c3fd9f9e41/12936_2017_2104_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/5683316/9fcc0d0146f1/12936_2017_2104_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/5683316/35adcb6a283c/12936_2017_2104_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/5683316/83d16554e72f/12936_2017_2104_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/5683316/69f55e1b6870/12936_2017_2104_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/5683316/84b82ade1a84/12936_2017_2104_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/5683316/da4458431e4c/12936_2017_2104_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/5683316/70c3fd9f9e41/12936_2017_2104_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/5683316/9fcc0d0146f1/12936_2017_2104_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/5683316/35adcb6a283c/12936_2017_2104_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/5683316/83d16554e72f/12936_2017_2104_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/5683316/69f55e1b6870/12936_2017_2104_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/5683316/84b82ade1a84/12936_2017_2104_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/5683316/da4458431e4c/12936_2017_2104_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/5683316/70c3fd9f9e41/12936_2017_2104_Fig7_HTML.jpg

相似文献

1
Expanding malaria diagnosis and treatment in Lao PDR: lessons learned from a public-private mix initiative.老挝人民民主共和国扩大疟疾诊断和治疗:公私混合举措的经验教训。
Malar J. 2017 Nov 13;16(1):460. doi: 10.1186/s12936-017-2104-5.
2
The malaria testing and treatment landscape in the southern Lao People's Democratic Republic (PDR).老挝人民民主共和国南部的疟疾检测与治疗情况
Malar J. 2017 Apr 25;16(1):169. doi: 10.1186/s12936-017-1769-0.
3
Private Sector Contributions to National Malaria Surveillance Systems in Elimination Settings: Lessons Learned from Cambodia, Lao PDR, Myanmar, and Vietnam.私营部门对消除环境中国家疟疾监测系统的贡献:柬埔寨、老挝人民民主共和国、缅甸和越南的经验教训。
Am J Trop Med Hyg. 2022 Dec 19;108(2_Suppl):14-23. doi: 10.4269/ajtmh.22-0147. Print 2023 Feb 2.
4
Expanding access to parasite-based malaria diagnosis through retail drug shops in Tanzania: evidence from a randomized trial and implications for treatment.通过坦桑尼亚的零售药店扩大基于寄生虫的疟疾诊断服务:一项随机试验的证据及其对治疗的影响
Malar J. 2017 Jan 3;16(1):6. doi: 10.1186/s12936-016-1658-y.
5
Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand.私营部门在大湄公河次区域实现疟疾消除方面的机遇与威胁:柬埔寨、老挝、缅甸和泰国疟疾销售点调查结果
Malar J. 2017 May 2;16(1):180. doi: 10.1186/s12936-017-1800-5.
6
The malaria testing and treatment landscape in mainland Tanzania, 2016.2016年坦桑尼亚大陆的疟疾检测与治疗情况
Malar J. 2017 Apr 24;16(1):202. doi: 10.1186/s12936-017-1819-7.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Treatment-seeking patterns for malaria in pharmacies in five sub-Saharan African countries.撒哈拉以南非洲五个国家药店中疟疾的就诊模式。
Malar J. 2017 Aug 29;16(1):353. doi: 10.1186/s12936-017-1997-3.
9
Improving rational use of ACTs through diagnosis-dependent subsidies: Evidence from a cluster-randomized controlled trial in western Kenya.通过基于诊断的补贴来改善抗疟药的合理使用:来自肯尼亚西部一项集群随机对照试验的证据。
PLoS Med. 2018 Jul 17;15(7):e1002607. doi: 10.1371/journal.pmed.1002607. eCollection 2018 Jul.
10
Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia.在私营部门推广社会营销的快速诊断检测试剂和青蒿琥酯:柬埔寨十年的经验。
Malar J. 2011 Aug 18;10:243. doi: 10.1186/1475-2875-10-243.

引用本文的文献

1
Genetic surveillance of Plasmodium falciparum populations following treatment policy revisions in the Greater Mekong Subregion.大湄公河次区域治疗政策修订后恶性疟原虫种群的基因监测。
Nat Commun. 2025 May 20;16(1):4689. doi: 10.1038/s41467-025-59946-1.
2
Factors associated with knowledge on HIV, TB and malaria among pregnant women and their perception of access to RDTs for HIV, TB and malaria in Savannakhet Province, Lao PDR.老挝沙湾拿吉省孕妇中与艾滋病毒、结核病和疟疾知识相关的因素及其对获得艾滋病毒、结核病和疟疾快速诊断检测的看法
BMC Pregnancy Childbirth. 2025 Apr 12;25(1):438. doi: 10.1186/s12884-025-07543-x.
3
Malaria epidemiology, surveillance and response for elimination in Lao PDR.

本文引用的文献

1
Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand.私营部门在大湄公河次区域实现疟疾消除方面的机遇与威胁:柬埔寨、老挝、缅甸和泰国疟疾销售点调查结果
Malar J. 2017 May 2;16(1):180. doi: 10.1186/s12936-017-1800-5.
2
Targeting populations at higher risk for malaria: a survey of national malaria elimination programmes in the Asia Pacific.针对疟疾高风险人群:亚太地区国家疟疾消除计划调查
Malar J. 2016 May 10;15(1):271. doi: 10.1186/s12936-016-1319-1.
3
Engaging the private sector to increase tuberculosis case detection: an impact evaluation study.
老挝消除疟疾的流行病学、监测和应对。
Infect Dis Poverty. 2024 May 23;13(1):35. doi: 10.1186/s40249-024-01202-7.
4
Deforestation inhibits malaria transmission in Lao PDR: a spatial epidemiology using Earth observation satellites.森林砍伐抑制了老挝疟疾的传播:利用地球观测卫星的空间流行病学研究。
Trop Med Health. 2023 Nov 2;51(1):60. doi: 10.1186/s41182-023-00554-4.
5
Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion.大湄公河次区域部署三药联合疗法的策略。
Malar J. 2023 Sep 6;22(1):261. doi: 10.1186/s12936-023-04666-4.
6
Point-of-care testing in private pharmacy and drug retail settings: a narrative review.即时检测在私人药店和药品零售环境中的应用:叙述性综述。
BMC Infect Dis. 2023 Aug 23;23(1):551. doi: 10.1186/s12879-023-08480-w.
7
India could harness public-private partnerships to achieve malaria elimination.印度可以利用公私合作伙伴关系来实现消除疟疾的目标。
Lancet Reg Health Southeast Asia. 2022 Sep 12;5:100059. doi: 10.1016/j.lansea.2022.100059. eCollection 2022 Oct.
8
Integrating private health facilities in government-led health systems: a case study of the public-private mix approach in Ethiopia.将私立医疗机构纳入政府主导的卫生系统中:以埃塞俄比亚公私混合模式为例
BMC Health Serv Res. 2022 Dec 3;22(1):1477. doi: 10.1186/s12913-022-08769-7.
9
Malaria outbreak in Laos driven by a selective sweep for Plasmodium falciparum kelch13 R539T mutants: a genetic epidemiology analysis.老挝疟疾疫情由恶性疟原虫kelch13 R539T 突变体的选择清除驱动:遗传流行病学分析。
Lancet Infect Dis. 2023 May;23(5):568-577. doi: 10.1016/S1473-3099(22)00697-1. Epub 2022 Nov 30.
10
Private Sector Contributions to National Malaria Surveillance Systems in Elimination Settings: Lessons Learned from Cambodia, Lao PDR, Myanmar, and Vietnam.私营部门对消除环境中国家疟疾监测系统的贡献:柬埔寨、老挝人民民主共和国、缅甸和越南的经验教训。
Am J Trop Med Hyg. 2022 Dec 19;108(2_Suppl):14-23. doi: 10.4269/ajtmh.22-0147. Print 2023 Feb 2.
吸引私营部门参与提高结核病病例检出率:一项影响评估研究。
Lancet Infect Dis. 2012 Aug;12(8):608-16. doi: 10.1016/S1473-3099(12)70116-0. Epub 2012 Jun 14.
4
Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges.被忽视疾病药物研发倡议:被忽视疾病药物研发模式:现状与未来挑战。
Future Med Chem. 2011 Sep;3(11):1361-71. doi: 10.4155/fmc.11.102.
5
Innovative public-private partnerships to maximize the delivery of anti-malarial medicines: lessons learned from the ASAQ Winthrop experience.创新的公私合作伙伴关系以最大限度地提供抗疟药物:从 ASAQ Winthrop 经验中吸取的教训。
Malar J. 2011 May 23;10:143. doi: 10.1186/1475-2875-10-143.
6
Public-private partnerships in blindness prevention: reaching beyond the eye.预防失明领域的公私伙伴关系:超越眼科范畴
Eye (Lond). 2005 Oct;19(10):1050-6. doi: 10.1038/sj.eye.6701961.
7
Public-private mix DOTS in the Philippines.菲律宾公私混合的直接观察治疗短程疗法
Tuberculosis (Edinb). 2003;83(1-3):173-6. doi: 10.1016/s1472-9792(02)00067-7.